BANELLI, BARBARA
 Distribuzione geografica
Continente #
EU - Europa 987
Totale 987
Nazione #
IT - Italia 987
Totale 987
Città #
Genova 616
Rapallo 187
Genoa 181
Bordighera 3
Totale 987
Nome #
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 164
Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma 155
PREVENZIONE DELLA RESISTENZA A FARMACI CHEMIOTERAPICI: IL GLIOBLASTOMA COME PARADIGMA 104
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 102
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 91
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of Fc gamma RIIIA/Fc gamma RIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines 87
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization 73
Phenotypic characterization of tumor CTLA-4 expression in melanoma tissues and its possible role in clinical response to Ipilimumab 56
Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression 51
Characterization of soluble PD-L1 in pleural effusions of mesothelioma patients: potential implications in the immune response and prognosis 49
Evaluation of BRCA1 promoter hypermethylation (B1PHM) in ovarian carcinomas (OC) 31
A multidrug approach to modulate the mitochondrial metabolism impairment and relative oxidative stress in fanconi anemia complementation group a 30
Two calix[4]pyrroles as potential therapeutics for castration-resistant prostate cancer 29
In uveal melanoma Gα-protein GNA11 mutations convey a shorter disease-specific survival and are more strongly associated with loss of BAP1 and chromosomal alterations than Gα-protein GNAQ mutations 18
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study 1
Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study 1
Totale 1.042
Categoria #
all - tutte 3.932
article - articoli 3.673
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 0 9
2019/2020240 9 6 4 14 22 29 34 20 33 37 28 4
2020/2021145 6 14 15 4 12 21 12 12 8 22 11 8
2021/2022196 10 7 10 22 5 15 9 34 13 29 15 27
2022/2023213 15 20 3 18 34 36 12 15 23 2 33 2
2023/2024163 5 12 4 23 13 29 12 14 20 3 6 22
Totale 1.042